Abstract
Spinal and bulbar muscular atrophy (SBMA) is regarded as a disorder with adult onset between third and fifth decade of life. However, there is increasing evidence that SBMA may start already before adulthood. The present study investigated the following: (1) Which clinical manifestations have been described so far in the literature as initial manifestations? (2) Which was the age at onset of these manifestations? and (3) Is age at onset dependent on the CAG-repeat length if non-motor manifestations are additionally considered? Data for this review were identified by searches of MEDLINE using appropriate search terms. Onset manifestations in SBMA can be classified as frequent, rare, motor, non-motor, or questionable. Frequent are muscle weakness, cramps, fasciculations/twitching, tremor, dysarthria, dysphagia, or gynecomastia. Rare are myalgia, easy fatigability, exercise intolerance, polyneuropathy, hyper-CKemia, under-masculinized genitalia, scrotal hypospadias, microphallus, laryngospasm, or oligospermia. Questionable manifestations include sensory disturbances, cognitive impairment, increased pituitary volume, diabetes, reduced tongue pressure, elevated creatine-kinase, or low androgens/high estrogens. Age at onset is highly variable ranging from 4–76 years. Non-motor manifestations develop usually before motor manifestations. Age at onset depends on what is considered as an onset manifestation. Considering non-motor onset manifestations, age at onset is independent of the CAG-repeat size. In conclusion, age at onset of SBMA depends on what is regarded as onset manifestation. If non-motor manifestations are additionally considered, age at onset is independent of the CAG-repeat length. Since life expectancy is hardly reduced in SBMA, re-investigation of patients from published studies with regard to their initial disease profiles is recommended.
Similar content being viewed by others
References
Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR (1993) Kennedy’s disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 43:791–794
Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G (2006) Natural history of spinal and bulbar muscular atrophy (BSMA): a study of 223 Japanese patients. Brain 129:1446–1455
Biancalana V, Serville F, Pommier J, Julien J, Hanauer A, Mandel JL (1992) Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum Mol Genet 1:255–258
Chevalier-Larsen ES, O’Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, Merry DE (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24:4778–4786
Dias FA, Munhoz RP, Raskin S, Werneck LC, Teive HA (2011) Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy’s disease). Clinics (Sao Paulo) 66:955–957
Echaniz-Laguna A, Rousso E, Anheim M, Fleury M, Cossée M, Tranchant C (2005) A clinical, neurophysiological and molecular study of 12 patients from 4 families with spinal and bulbar muscular atrophy. Rev Neurol (Paris) 161:437–444
Fan R, Zhang L, Zhang J, Shao B, Pan D, Lyu J (2014) Investigation of a family with Kennedy disease by genetic analysis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 31:750–753
Finsterer J (2010) Perspectives of Kennedy’s disease. J Neurol Sci 298:1–10
Fratta P, Nirmalananthan N, Masset L, Skorupinska I, Collins T, Cortese A, Pemble S, Malaspina A, Fisher EM, Greensmith L, Hanna MG (2014) Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology 82:2077–2084
Fu SC, Kuo HC, Chu CC, Wu YR, Ro LS, Liu CS, Huang CC (2013) Long-term follow-up of spinal and bulbar muscular atrophy in Taiwan. J Formos Med Assoc 112:326–331
Gómez-Calero V, Cornejo-Olivas M, Ortega O, Marca V, Lindo-Samanamud S, Flores M, Torres-Ramírez L, Mazzetti P (2013) Kennedy disease in Peru: first cases with molecular diagnosis. Rev Peru Med Exp Salud Publica 30:331–335
Grunseich C, Rinaldi C, Fischbeck KH (2014) Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis 20:6–9
Guidetti D, Sabadini R, Ferlini A, Torrente I (2001) Epidemiological survey of X-linked bulbar and spinal muscular atrophy, or Kennedy disease, in the province of Reggio Emilia, Italy. Eur J Epidemiol 17:587–591
Guidetti D, Vescovini E, Motti L, Ghidoni E, Gemignani F, Marbini A, Patrosso MC, Ferlini A, Solime F (1996) X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neurophysiological, neuropathological, neuropsychological and molecular study of a large family. J Neurol Sci 135:140–148
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G (2012) Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. J Neurol 259:712–719
Hemmi S, Inoue K, Kutoku Y, Rikimaru M, Murakami T, Sunada Y (2009) Two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy. Rinsho Shinkeigaku 49:22–26
Hui AC, Cheung PT, Tang AS, Fu M, Wong L, Kay R, Hong Kong Neuromuscular Disease Study Group (2004) Clinical and electrophysiological features in Chinese patients with Kennedy’s disease. Clin Neurol Neurosurg 106:309–312
Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, Ishikawa A, Miyatani N, Nagashima M, Ishikawa Y, Sahashi K, et al. (1992) Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300–2302
Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843–854
Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18:671–680
Kooy RF, Reyniers E, Storm K, Vits L, van Velzen D, de Ruiter PE, Brinkmann AO, de Paepe A, Willems PJ (1999) CAG repeat contraction in the androgen receptor gene in three brothers with mental retardation. Am J Med Genet 85:209–213
Kuhlenbäumer G, Bocchicchio M, Kress W, Young P, Oberwittler C, Stögbauer F (1998) X-chromosomal recessive spinobulbar muscular atrophy (Kennedy type). Description of a family, clinical aspects, molecular genetics, differential diagnosis and therapy. Nervenarzt 69:660–665
La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, Yee WC, Fischbeck KH (1992) Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 2:301–304
La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79
Lai TH, Liu RS, Yang BH, Wang PS, Lin KP, Lee YC, Soong BW (2013) Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy’s disease): a pilot study of PET. J Neurol Sci 335:139–144
Lu M, Wang XZ, Zhang J, Zhao HY, Sun AP, Song LG, Fan DS (2009) The correlation of CAGs repeat size with age of onset in patients with Kennedy’s disease. Zhonghua Nei Ke Za Zhi 48:284–286
MacLean HE, Choi WT, Rekaris G, Warne GL, Zajac JD (1995) Abnormal androgen receptor binding affinity in subjects with Kennedy’s disease (spinal and bulbar muscular atrophy). J Clin Endocrinol Metab 80:508–516
Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Araki A, Watanabe H, Tanaka S, Yamamoto M, Sobue G (2014) Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Neurology 82:255–262
Mariotti C, Castellotti B, Pareyson D, Testa D, Eoli M, Antozzi C, Silani V, Marconi R, Tezzon F, Siciliano G, Marchini C, Gellera C, Donato SD (2000) Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord 10:391–397
Morrison PJ, Mirakhur M, Patterson VH (1998) Discordant repeat size and phenotype in Kennedy syndrome. Clin Genet 53:276–277
Ni W, Chen S, Qiao K, Wang N, Wu ZY (2015) Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy. PLoS One 10(3):e0122279. doi:10.1371/journal.pone.0122279.eCollection2015
Nishiyama A, Sugeno N, Tateyama M, Nishiyama S, Kato M, Aoki M (2014) Postural leg tremor in X-linked spinal and bulbar muscular atrophy. J Clin Neurosci 21:799–802
Ogata T, Muroya K, Ishii T, Suzuki Y, Nakada T, Sasagawa I (2001) Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene. Clin Endocrinol 54:835–838
Ou-Yang ZY, Song SJ, Liu JR, Zhang BR, Wu DW (2011) Clinical and genetic analysis of a pedigree of Kennedy disease. Zhejiang Da Xue Xue Bao Yi Xue Ban 40:555–558
Pieper CC, Teismann IK, Konrad C, Heindel WL, Schiffbauer H (2013) Changes of pituitary gland volume in Kennedy disease. AJNR Am J Neuroradiol 34:2294–2297
Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, Lehky TJ, Shrader JA, Levy EW, Harris-Love M, Di Prospero NA, Fischbeck KH (2009) Clinical features of spinal and bulbar muscular atrophy. Brain 132:3242–3251
Rocchi C, Greco V, Urbani A, Di Giorgio A, Priori M, Massa R, Bernardi G, Marfia GA (2011) Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease). Muscle Nerve 44:737–740
Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59:770–772
Serratrice G, Pellissier JF, Pouget J (1988) X-linked bulbo-spinal neuronopathy. Kennedy’s syndrome. Rev Neurol (Paris) 144:756–758
Shimada N, Sobue G, Doyu M, Yamamoto K, Yasuda T, Mukai E, Kachi T, Mitsuma T (1995) X-linked recessive bulbospinal neuronopathy: clinical phenotypes and CAG repeat size in androgen receptor gene. Muscle Nerve 18:1378–1384
Soukup GR, Sperfeld AD, Uttner I, Karitzky J, Ludolph AC, Kassubek J, Schreiber H (2009) Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (BSMA): a controlled neuropsychological study of 20 patients. J Neurol 256:1869–1875
Sperfeld AD, Hanemann CO, Ludolph AC, Kassubek J (2005) Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology 64:753–754
Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Häussler J, Ludolph AC, Hanemann CO (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59:1921–1926
Tanaka S, Banno H, Katsuno M, Suzuki K, Suga N, Hashizume A, Mano T, Araki A, Watanabe H, Adachi H, Tatsumi H, Yamamoto M, Sobue G (2014) Distinct acoustic features in spinal and bulbar muscular atrophy patients with laryngospasm. J Neurol Sci 337:193–200
Vandenberghe N, Bouhour F, Petiot P, Gonnaud PM, Latour P, Broussolle E, Vial C (2009) Multiple phenotypic manifestations of X-linked spinobulbar muscular atrophy. Rev Neurol (Paris) 165:31–37
Xie MQ, Li XG, Cui LY, Liu MS, Li BH, Zhao YH (2010) Clinical features and genetic diagnosis of Kennedy disease. Zhonghua Yi Xue Za Zhi 90:2498–2500
Yang J, Zhang C, Hu ZH, Zhan YX, Cao JQ, Ren H (2010) Study on clinical manifestation, genotype and genetic characteristics of two Kennedy disease pedigrees. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27:125–131
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finsterer, J., Soraru, G. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease). J Mol Neurosci 58, 321–329 (2016). https://doi.org/10.1007/s12031-015-0663-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-015-0663-x